- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alkem Laboratories Limited — Updates, 21-03-2026: Press Release
21-03-2026 | 12:16 pm
21-03-2026 | 12:16 pm
Alkem Labs launched Semaglutide injection in India for type-2 diabetes and chronic weight management. Priced affordably from INR 450/week (INR 1,800/month), boosting patient access and improving health outcomes.
No comments yet. Be the first to comment!